340 related articles for article (PubMed ID: 11532378)
1. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
Sato S; Hasegawa M; Takehara K
J Dermatol Sci; 2001 Oct; 27(2):140-6. PubMed ID: 11532378
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: A potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors.
Taylan A; Birlik M; Kenar G; Toprak B; Gundogdu B; Gurler O; Karakas B; Akıncı B; Sisman AR
Mod Rheumatol; 2019 Jul; 29(4):619-624. PubMed ID: 30001654
[No Abstract] [Full Text] [Related]
6. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
Clin Rheumatol; 2011 Jun; 30(6):825-30. PubMed ID: 21246230
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
Tang J; Lei L; Pan J; Zhao C; Wen J
Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
[TBL] [Abstract][Full Text] [Related]
8. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
[TBL] [Abstract][Full Text] [Related]
10. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
[TBL] [Abstract][Full Text] [Related]
11. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
[TBL] [Abstract][Full Text] [Related]
12. Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.
Dziankowska-Bartkowiak B; Zalewska A; Sysa-Jedrzejowska A
Med Sci Monit; 2004 May; 10(5):CR202-8. PubMed ID: 15114270
[TBL] [Abstract][Full Text] [Related]
13. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
[TBL] [Abstract][Full Text] [Related]
15. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M; Fujimoto M; Kikuchi K; Takehara K
J Rheumatol; 1997 Feb; 24(2):328-32. PubMed ID: 9034992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]